Comparison of intramuscular ketorolac tromethamine and morphine sulfate for analgesia of pain after major surgery

Ketorolac tromethamine is a new injectable nonnarcotic analgesic. In a parallel, double-blind study, the analgesic efficacies of single intramuscular doses of ketorolac 10, 30 and 90 mg were compared with those of morphine sulfate 6 and 12 mg. Two hundred forty-one patients were categorized accordin...

Full description

Saved in:
Bibliographic Details
Published inPharmacotherapy Vol. 6; no. 5; p. 253
Main Authors Yee, J P, Koshiver, J E, Allbon, C, Brown, C R
Format Journal Article
LanguageEnglish
Published United States 01.09.1986
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Ketorolac tromethamine is a new injectable nonnarcotic analgesic. In a parallel, double-blind study, the analgesic efficacies of single intramuscular doses of ketorolac 10, 30 and 90 mg were compared with those of morphine sulfate 6 and 12 mg. Two hundred forty-one patients were categorized according to type of surgical procedure and severity of pain. Pain intensity and pain relief were assessed for 6 hours by scoring standard verbal and visual analog scales. Patients receiving ketorolac 10, 30 or 90 mg or morphine (MS) 12 mg all had significantly better pain relief in almost all measurements performed than those receiving MS 6 mg (p less than 0.05). Ketorolac 10 and 30 mg were as effective as morphine 12 mg during the entire 6-hour observation period, and ketorolac 90 mg was more effective than morphine 12 mg during the entire 6 hours. Patients with pain related to major surgery (e.g., cholecystectomy and abdominal hysterectomy) were better able to distinguish analgesic potency of morphine than those having less traumatic procedures (e.g., tendon and ligament repairs).
ISSN:0277-0008
DOI:10.1002/j.1875-9114.1986.tb03485.x